好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Influence of Live-Online 好色先生 on Multiple Sclerosis Disease Management: Trends in Medical Knowledge and Practice Behaviors from Novice to Expert Clinicians
Multiple Sclerosis
P1 - Poster Session 1 (5:30 PM-6:30 PM)
15-098
To address practice gaps among clinicians who care for patients with multiple sclerosis (MS), CMSC and PlatformQ produced a multi-session continuing education (CME) activity for all MS practitioners, from novice to experienced, and evaluated learner responses to assess the influence of education.
Early treatment of MS with disease-modifying therapies (DMTs) has become widely accepted in the MS professional community, yet remains challenging with the heterogeneous nature of MS and variety of DMTs.
Three 1-hour video CME activities with slides, polling/live questions launched live-online June 14, 2018, to remain on-demand through June 14, 2018 at . For each session, CME test questions were administered at 3 time points (pre-, immediate post-, 8-weeks post). Responses from CME test, polling/live, and 8 weeks post activity survey were analyzed to determine engagement, lessons learned, and continuing gaps. McNemar test compared matched pair responses (pre/post & pre/8wk, respectively). Effect size was computed using Cohen’s d.
147 of 448 learners completed questions from all 3 time points. Learners were evenly spread in years of experience with most (70%) managing <10 patients/week. Most reported the activity positively impacted patient experience and outcome (71%, with 95 qualitative write-in examples), and their clinical practice (88%, 112 write-ins). Statistically significant improvements from 4 competency and 4 knowledge questions were observed on: individualizing treatment considering comorbidities, disease activity and disability, pregnancy and MS, appropriate follow-up measures, patient priorities, emerging DMTs, and induction therapy. 好色先生 gaps were identified in assessing disease severity, progressive disease, monoclonal antibodies, risk stratification, women with MS, shared decision making, sequencing and induction.
From novice to long-time practitioners, live-online education on MS disease management can positively influence patient experience, clinician performance, competence, and knowledge. Ongoing education is needed as our understanding of MS pathophysiology and disease management evolve.
Authors/Disclosures
Anne C. Roc, PhD
PRESENTER 		No disclosure on file
No disclosure on file
Jerry S. Wolinsky, MD, FAAN (McGovern Medical School, UTHealth) Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
June Halper, RN, ANP (CMSC) Ms. Halper has nothing to disclose.